Audit committee

Gyre Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update

Retrieved on: 
Tuesday, March 26, 2024
Hepatitis, KPMG, GNI, Cirrhosis, Patient, Chronic obstructive pulmonary disease, Sale, Coagulopathy, Ernst & Young, Idiopathic pulmonary fibrosis, Fibrosis, Therapy, COPD, Marketing, Partnership, Arthur Andersen, Audit committee, SAN, Safety, CVR, CHB, Fatty liver disease, Prevalence, Pharmacy, Hospital, Research, Acquisition, TGF, Pirfenidone, GAAP, Toxicity, Inflammation, Accounting, Entecavir, Loss, Orthostatic hypertension, IPF, Partner, NASH, Category 1, Pharmaceutical industry

Mr. Nussbaum brings nearly four decades of experience in accounting and financial reporting in the U.S. and Asia Pacific Region.

Key Points: 
  • Mr. Nussbaum brings nearly four decades of experience in accounting and financial reporting in the U.S. and Asia Pacific Region.
  • In October 2023, Gyre (formerly known as Catalyst Biosciences, Inc. (“Catalyst”)) completed the previously announced business combination with GNI Group Ltd. (“GNI”) and related entities.
  • In October 2023, Gyre Pharmaceuticals completed enrollment of its Phase 3 trial in patients with CHB-associated liver fibrosis in the PRC.
  • Use of Non-GAAP Financial Measures by Gyre Therapeutics, Inc.
    Gyre reports financial results in accordance with accounting principles generally accepted in the United States (“GAAP”).

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Nextdoor, Snowflake, and Chemours and Encourages Investors to Contact the Firm

Retrieved on: 
Tuesday, March 26, 2024
Transport, Form 10-K, P.C, Audit committee, Air conditioning, Electronics, Snowflake Inc., ARPU, Annual report, Ethics, Internet, News, Controller, Acquisition, Refrigeration, IPO, Networking hardware, Senior, SNOW, Adjustment, Growth, CFO, COVID-19, Complaint, Plastic, Cryptocurrency

On this news, the price of Nextdoor Class A common stock declined approximately 14%.

Key Points: 
  • On this news, the price of Nextdoor Class A common stock declined approximately 14%.
  • On this news, the price of Nextdoor Class A common stock fell approximately 11%, further damaging investors.
  • Prior to and during the Class Period, Chemours also set and publicized certain criteria for executive compensation.
  • For more information on the Chemours class action go to: https://bespc.com/cases/CC

THE CHEMOURS COMPANY investors: Please contact the Portnoy Law Firm to recover your losses; May 13, 2024 deadline

Retrieved on: 
Monday, March 25, 2024
Annual report, Ethics, CC, News, Controller, Free cash flow, Senior, Audit committee

LOS ANGELES, March 25, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises The Chemours Company (“Chemours” or the “Company”) (NYSE: CC) investors that a lawsuit was filed on behalf of investors that purchased Chemours securities between February 10, 2023 and February 28, 2024, inclusive (the “Class Period”).

Key Points: 
  • LOS ANGELES, March 25, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises The Chemours Company (“Chemours” or the “Company”) (NYSE: CC) investors that a lawsuit was filed on behalf of investors that purchased Chemours securities between February 10, 2023 and February 28, 2024, inclusive (the “Class Period”).
  • The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors’ options for pursuing claims to recover their losses.
  • Following these revelations, Chemours’ share price plummeted by $9.05, or over 31%, ending the day at $28.72 per share on February 29, 2024.
  • The Portnoy Law Firm represents investors in pursuing claims caused by corporate wrongdoing.

Brighthouse Financial Appoints Michael J. Inserra and Lizabeth H. Zlatkus to Board of Directors

Retrieved on: 
Tuesday, April 9, 2024
Professional Services, Other Professional Services, Insurance, Finance, Asset Management, Personal Finance, Brighthouse Financial, Indivior, Inserra Supermarkets, Risk management, Ernst & Young, The Hartford, EY, Audit committee, Lisabeth, Moore Capital Management, Retirement, Management

Brighthouse Financial, Inc. (“Brighthouse Financial” or the “Company”) (Nasdaq: BHF) announced that today its Board of Directors (the “Board”) appointed Michael J.

Key Points: 
  • Brighthouse Financial, Inc. (“Brighthouse Financial” or the “Company”) (Nasdaq: BHF) announced that today its Board of Directors (the “Board”) appointed Michael J.
  • (“Mike”) Inserra and Lizabeth H. Zlatkus as independent members of the Board.
  • Mr. Inserra and Ms. Zlatkus were also each designated by the Board as an “audit committee financial expert” under applicable U.S. Securities and Exchange Commission rules and appointed to serve on the Audit Committee.
  • “Mike and Lizabeth each bring valuable experience in the insurance and financial services industries, along with strong leadership skills, financial expertise and deep knowledge of operations and risk management,” said C. Edward (“Chuck”) Chaplin, chairman of the Board, Brighthouse Financial.

SilverBow Resources Announces Filing of Definitive Proxy Statement and Mails Letter to Shareholders

Retrieved on: 
Tuesday, April 9, 2024
Professional Services, Finance, TSR, Letter, Risk management, ALL, Annual general meeting, History, Strategic planning, Acquisition, XOP, Eagle Ford, Dallas, KTG, Chevron Corporation, Audit committee, Management

In conjunction with the definitive proxy filing, the Company has mailed a letter to SilverBow shareholders recommending they vote for SilverBow’s three independent, highly qualified directors on the WHITE proxy card – Gabriel L. Ellisor, Kathleen McAllister and Charles W. Wampler.

Key Points: 
  • In conjunction with the definitive proxy filing, the Company has mailed a letter to SilverBow shareholders recommending they vote for SilverBow’s three independent, highly qualified directors on the WHITE proxy card – Gabriel L. Ellisor, Kathleen McAllister and Charles W. Wampler.
  • Kimmeridge is pursuing a proxy fight to further its attempt to gain control of the Company and force a combination between SilverBow and KTG on terms that are unfavorable to SilverBow shareholders.
  • The full text of the letter follows:
    The SilverBow Resources, Inc. (“SilverBow” or the “Company”) Board of Directors (the “Board”) and management team are committed to maximizing shareholder value.
  • Since early 2023, SilverBow has added four new independent directors to our Board, while significantly increasing the Board’s diversity.

Notice of Annual General Meeting in Starbreeze AB (publ)

Retrieved on: 
Tuesday, April 9, 2024
Remuneration, Annual, PwC, Documentation, Exercise, Committee, Address, Proxy, AB, Euroclear, Starbreeze Studios, Acquisition, Bank statement, Annual general meeting, Swedish, Post office box, Companies Act, Audit committee

556551-8932, are given notice of the Annual General Meeting to be held on Wednesday 15 May 2024 at 13.00 CEST in Styrelserummet, Citykonferensen, Malmskillnadsgatan 46, Stockholm, Sweden.

Key Points: 
  • 556551-8932, are given notice of the Annual General Meeting to be held on Wednesday 15 May 2024 at 13.00 CEST in Styrelserummet, Citykonferensen, Malmskillnadsgatan 46, Stockholm, Sweden.
  • The Board of Directors has decided that shareholders shall be able to exercise their voting rights at the Annual General Meeting also by postal voting.
  • A) Anyone wishing to attend the meeting room in person or through a representative must:
    be listed as a shareholder in the presentation of the share register prepared by Euroclear Sweden AB concerning the circumstances on Monday 6 May 2024, and
    give notice of participation no later than on Wednesday 8 May 2024 to the address Starbreeze AB, "Annual General Meeting 2024", c/o Euroclear Sweden AB, P.O.
  • Completed and signed forms for postal voting can be sent by mail to Starbreeze AB, "Annual General Meeting 2024", c/o Euroclear Sweden AB, P.O.

THE CHEMOURS COMPANY SHAREHOLDER ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against The Chemours Company (NYSE: CC)

Retrieved on: 
Monday, March 25, 2024
Annual report, Ethics, CC, District court, Controller, News, Senior, Complaint, Court, Advertising, Audit committee, Security (finance)

NEW YORK, March 25, 2024 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP:

Key Points: 
  • NEW YORK, March 25, 2024 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP:
    Do you, or did you, own shares of The Chemours Company (NYSE: CC)?
  • Bernstein Liebhard LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or acquired the common stock of The Chemours Company (“Chemours” or the “Company”) (NYSE: CC) between February 10, 2023 and February 28, 2024, inclusive (the “Class Period”).
  • If you purchased or acquired Chemours common stock, and/or would like to discuss your legal rights and options please visit The Chemours Company Shareholder Class Action Lawsuit or contact Investor Relations Manager Peter Allocco at (212) 951-2030 or [email protected] .
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

Comtech Telecommunications (CMTL) Tanks After Firing CEO and Posting Disastrous Quarterly Results – Hagens Berman

Retrieved on: 
Monday, March 25, 2024
SAN, Telecommunications, Person, CMTL, Hagens Berman, Audit committee, Life insurance

SAN FRANCISCO, March 25, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Comtech Telecommunications Corp. (NASDAQ: CMTL) investors who suffered substantial losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, March 25, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Comtech Telecommunications Corp. (NASDAQ: CMTL) investors who suffered substantial losses to submit your losses now .
  • Comtech Telecommunications Corp. shares are trading down nearly 40% over the last week after the company sacked its CEO for cause and delivered disappointing quarterly results.
  • The timing and circumstances of these recent events have prompted Hagens Berman, a prominent investors’ rights law firm, to open an investigation into potential violations of the U.S. securities laws.
  • “We’re investigating whether Comtech and its management may have made misrepresentations and omissions to investors,” said Reed Kathrein, the Hagens Berman partner leading the firm’s investigation.

FEMSA Shareholders’ Meeting Resolutions

Retrieved on: 
Monday, March 25, 2024
FMX, Annual, Annual report, BMV, Committee, ADS, Audit committee, Shareholder, Bank statement, Woman, Operation, Series

de C.V. (“FEMSA” or the “Company”) (NYSE: FMX; BMV: FEMSAUBD, FEMSAUB) held its Annual Shareholders’ Meeting today (“the Shareholders’ Meeting”), during which the shareholders approved the consolidated financial statements for the year ended December 31, 2023, the 2023 CEO’s annual report and the opinion of the Board of Directors for the year 2023.

Key Points: 
  • de C.V. (“FEMSA” or the “Company”) (NYSE: FMX; BMV: FEMSAUBD, FEMSAUB) held its Annual Shareholders’ Meeting today (“the Shareholders’ Meeting”), during which the shareholders approved the consolidated financial statements for the year ended December 31, 2023, the 2023 CEO’s annual report and the opinion of the Board of Directors for the year 2023.
  • In line with our goal of setting the standard for corporate governance best practices, the shareholders’ meeting elected Elane Stock and Olga Gonzalez Aponte as new independent directors.
  • Additionally, the Annual Shareholders’ Meeting declared and approved the payment of an extraordinary cash dividend of Ps.
  • For additional information, please refer to the Summary of Resolutions in the Shareholders Meeting section of our corporate website at: https://femsa.gcs-web.com/shareholder-meeting-information

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Chemours Company - CC

Retrieved on: 
Saturday, March 23, 2024
Prior, Chemours, News, Controller, LLP, Senior, Pomerantz, Audit committee

NEW YORK, March 23, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of The Chemours Company (“Chemours” or the “Company”) (NYSE: CC).

Key Points: 
  • NEW YORK, March 23, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of The Chemours Company (“Chemours” or the “Company”) (NYSE: CC).
  • 7980
    The investigation concerns whether Chemours and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.
  • The Firm has recovered billions of dollars in damages awards on behalf of class members.